Autres langues Numinus Wellness Inc.

Actions

NUMI

CA67054W1032

Marché Fermé - Toronto S.E. Autres places de cotation 21:47:55 30/04/2024			Varia. 5j.	Varia. 1 janv.
0,075 ^CAD	-.--%		-11,76 %	-31,82 %

17/04	Cybin choisit Cedar Clinical Research de Numinus Wellness Inc. comme site de recherche clinique pour son étude de phase 3 sur le CYB003	CI
15/04	Transcript : Numinus Wellness Inc., Q2 2024 Earnings Call, Apr 15, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003	17/04
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003	17/04
Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003	17/04
Numinus Wellness Drops 25% as it Explores Options for its Canadian Operations; FQ2 Profit Falls	15/04
Toronto Stocks Edge Lower; Parkland Shares Up After Rebuffing Call for Strategic Review	15/04
Numinus Wellness Exploring Options For Canadian Operations; Comes After It Posted QoQ Decrease in Q2 Revenue, Gross Profit	15/04
Numinus Wellness Brief: Co Has decided to Explore Opportunities to "Redefine, divest and/or discontinue" its Canadian clinical operations	15/04
Numinus Wellness Brief: Says To Focus on U.S. operations and Citing "Strategic Adjustments" in its Canadian Market Presence	15/04
Numinus Wellness Provides Corporate Update	15/04
Numinus Wellness Provides Corporate Update	15/04
Numinus Wellness Posts QoQ Decrease in Q2 Revenue, Gross Profit	15/04
An undisclosed buyer agreed to acquire Canadian clinical operations from Numinus Wellness Inc..	15/04
Numinus Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	13/04
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	13/04
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	13/04
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024	09/04
PharmAla Biotech Signs Sale Agreement with Numinus Wellness	26/03
Numinus Wellness Submits Clinical Trial Application to Health Canada	20/03
Numinus Wellness Brief: Says Submitted Clinical Trial Application	20/03
Numinus Wellness Submits Clinical Trial Application	20/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Numinus Wellness Inc.

Actions

NUMI

CA67054W1032

Autres langues

Filtres